date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.800609232668285.
The log-likelihood improved by 3.41.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.77.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.9074.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       16     1280     1013      842      352      351      345 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     301      200      134       87       43       21        6        4 
degree16 degree17 
       1        2 
1 
disease_progression 
H-positive risk:  869 851 131 837 465 115 905 435 132 60 139 61 
H-negative risk:  851 869 905 837 435 465 115 131 139 132 61 60 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
63 new agents 
2 
disease_progression 
H-positive risk:  868 857 131 836 459 116 905 433 134 61 140 60 
H-negative risk:  857 868 905 836 433 459 116 131 140 134 60 61 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
48 new agents 
3 
disease_progression 
H-positive risk:  868 861 133 838 455 119 905 425 135 60 142 59 
H-negative risk:  861 868 905 838 425 455 119 133 142 135 59 60 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
4 
disease_progression 
H-positive risk:  868 872 136 837 444 119 904 423 137 61 140 59 
H-negative risk:  872 868 904 837 423 444 119 136 140 137 59 61 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
5 
disease_progression 
H-positive risk:  869 876 136 840 438 120 901 424 137 62 139 58 
H-negative risk:  876 869 901 840 424 438 120 136 139 137 58 62 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 4 3 

clinical_engagement 
diagnosis 
demography 
72 new agents 
6 
disease_progression 
H-positive risk:  878 884 135 839 440 119 899 418 133 62 138 55 
H-negative risk:  884 878 899 839 418 440 119 135 138 133 55 62 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 5 4 

clinical_engagement 
diagnosis 
demography 
59 new agents 
7 
disease_progression 
H-positive risk:  879 885 135 842 438 120 892 418 133 64 139 55 
H-negative risk:  885 879 892 842 418 438 120 135 139 133 55 64 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 9 4 

clinical_engagement 
diagnosis 
demography 
60 new agents 
8 
disease_progression 
H-positive risk:  881 893 138 840 438 125 890 407 131 63 141 53 
H-negative risk:  893 881 890 840 407 438 125 138 141 131 53 63 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 13 4 

clinical_engagement 
diagnosis 
demography 
65 new agents 
9 
disease_progression 
H-positive risk:  881 899 136 844 433 127 888 403 131 65 141 52 
H-negative risk:  899 881 888 844 403 433 127 136 141 131 52 65 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 13 4 

clinical_engagement 
diagnosis 
demography 
57 new agents 
10 
disease_progression 
H-positive risk:  884 902 139 846 426 126 884 405 132 65 140 51 
H-negative risk:  902 884 884 846 405 426 126 139 140 132 51 65 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 14 4 

clinical_engagement 
diagnosis 
demography 
62 new agents 
11 
disease_progression 
H-positive risk:  887 904 142 846 421 127 878 406 135 63 141 50 
H-negative risk:  904 887 878 846 406 421 127 142 141 135 50 63 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 14 5 

clinical_engagement 
diagnosis 
demography 
64 new agents 
12 
disease_progression 
H-positive risk:  895 906 142 845 421 126 873 402 136 62 141 51 
H-negative risk:  906 895 873 845 402 421 126 142 141 136 51 62 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 16 6 

clinical_engagement 
diagnosis 
demography 
54 new agents 
13 
disease_progression 
H-positive risk:  831 830 125 919 426 117 940 400 146 62 154 50 
H-negative risk:  830 831 940 919 400 426 117 125 154 146 50 62 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 17 6 

clinical_engagement 
diagnosis 
demography 
210 new agents 
14 
disease_progression 
H-positive risk:  865 855 127 877 442 121 892 411 141 71 143 55 
H-negative risk:  855 865 892 877 411 442 121 127 143 141 55 71 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 22 6 

clinical_engagement 
diagnosis 
demography 
50 new agents 
15 
disease_progression 
H-positive risk:  865 853 127 885 440 125 885 412 143 67 142 56 
H-negative risk:  853 865 885 885 412 440 125 127 142 143 56 67 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 23 6 

clinical_engagement 
diagnosis 
demography 
55 new agents 
16 
disease_progression 
H-positive risk:  864 861 127 883 430 125 897 406 143 66 142 56 
H-negative risk:  861 864 897 883 406 430 125 127 142 143 56 66 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 24 6 

clinical_engagement 
diagnosis 
demography 
59 new agents 
17 
disease_progression 
H-positive risk:  863 860 128 893 423 126 898 405 144 63 140 57 
H-negative risk:  860 863 898 893 405 423 126 128 140 144 57 63 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 24 7 

clinical_engagement 
diagnosis 
demography 
62 new agents 
18 
disease_progression 
H-positive risk:  870 865 127 890 420 129 897 399 145 61 142 55 
H-negative risk:  865 870 897 890 399 420 129 127 142 145 55 61 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 27 9 

clinical_engagement 
diagnosis 
demography 
66 new agents 
19 
disease_progression 
H-positive risk:  870 868 129 892 416 129 894 397 146 62 143 54 
H-negative risk:  868 870 894 892 397 416 129 129 143 146 54 62 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 29 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
20 
disease_progression 
H-positive risk:  875 869 130 895 418 128 893 393 147 60 140 52 
H-negative risk:  869 875 893 895 393 418 128 130 140 147 52 60 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 30 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
21 
disease_progression 
H-positive risk:  889 867 130 899 410 129 883 394 148 59 140 52 
H-negative risk:  867 889 883 899 394 410 129 130 140 148 52 59 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 30 11 

clinical_engagement 
diagnosis 
demography 
63 new agents 
22 
disease_progression 
H-positive risk:  890 870 131 895 404 132 882 393 151 61 138 53 
H-negative risk:  870 890 882 895 393 404 132 131 138 151 53 61 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 30 11 

clinical_engagement 
diagnosis 
demography 
64 new agents 
23 
disease_progression 
H-positive risk:  899 877 132 893 400 135 878 380 153 60 139 54 
H-negative risk:  877 899 878 893 380 400 135 132 139 153 54 60 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
61 new agents 
24 
disease_progression 
H-positive risk:  904 875 130 900 396 132 881 377 151 60 139 55 
H-negative risk:  875 904 881 900 377 396 132 130 139 151 55 60 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 35 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
25 
disease_progression 
H-positive risk:  836 821 120 950 402 124 952 375 161 57 149 53 
H-negative risk:  821 836 952 950 375 402 124 120 149 161 53 57 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 34 13 

clinical_engagement 
diagnosis 
demography 
181 new agents 
26 
disease_progression 
H-positive risk:  855 843 123 910 419 125 912 393 156 61 151 52 
H-negative risk:  843 855 912 910 393 419 125 123 151 156 52 61 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 39 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
27 
disease_progression 
H-positive risk:  868 846 123 904 416 126 904 392 155 61 150 55 
H-negative risk:  846 868 904 904 392 416 126 123 150 155 55 61 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 40 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
28 
disease_progression 
H-positive risk:  869 852 125 900 413 127 908 390 152 62 149 53 
H-negative risk:  852 869 908 900 390 413 127 125 149 152 53 62 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 41 14 

clinical_engagement 
diagnosis 
demography 
62 new agents 
29 
disease_progression 
H-positive risk:  873 852 125 904 408 129 902 389 153 61 149 55 
H-negative risk:  852 873 902 904 389 408 129 125 149 153 55 61 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 42 14 

clinical_engagement 
diagnosis 
demography 
50 new agents 
30 
disease_progression 
H-positive risk:  872 861 126 901 406 129 900 388 154 61 147 55 
H-negative risk:  861 872 900 901 388 406 129 126 147 154 55 61 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 45 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
31 
disease_progression 
H-positive risk:  874 870 126 912 395 127 905 384 152 57 143 55 
H-negative risk:  870 874 905 912 384 395 127 126 143 152 55 57 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 45 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
32 
disease_progression 
H-positive risk:  877 868 125 908 393 127 913 382 150 57 143 57 
H-negative risk:  868 877 913 908 382 393 127 125 143 150 57 57 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 46 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
33 
disease_progression 
H-positive risk:  874 869 127 910 392 127 912 382 151 59 142 55 
H-negative risk:  869 874 912 910 382 392 127 127 142 151 55 59 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 44 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
34 
disease_progression 
H-positive risk:  878 868 127 909 393 128 908 380 152 61 142 54 
H-negative risk:  868 878 908 909 380 393 128 127 142 152 54 61 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 43 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
35 
disease_progression 
H-positive risk:  885 870 126 911 387 130 912 369 151 62 144 53 
H-negative risk:  870 885 912 911 369 387 130 126 144 151 53 62 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 43 17 

clinical_engagement 
diagnosis 
demography 
55 new agents 
36 
disease_progression 
H-positive risk:  888 867 126 916 389 129 911 370 149 61 144 50 
H-negative risk:  867 888 911 916 370 389 129 126 144 149 50 61 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 43 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
37 
disease_progression 
H-positive risk:  819 795 117 989 390 122 976 373 156 61 153 49 
H-negative risk:  795 819 976 989 373 390 122 117 153 156 49 61 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 48 17 

clinical_engagement 
diagnosis 
demography 
149 new agents 
38 
disease_progression 
H-positive risk:  835 809 115 964 405 120 942 401 145 69 143 52 
H-negative risk:  809 835 942 964 401 405 120 115 143 145 52 69 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 52 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
39 
disease_progression 
H-positive risk:  840 809 117 957 408 121 945 399 146 67 138 53 
H-negative risk:  809 840 945 957 399 408 121 117 138 146 53 67 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
40 
disease_progression 
H-positive risk:  844 809 114 959 408 123 945 395 148 66 137 52 
H-negative risk:  809 844 945 959 395 408 123 114 137 148 52 66 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
41 
disease_progression 
H-positive risk:  847 813 115 966 413 123 933 391 143 63 138 55 
H-negative risk:  813 847 933 966 391 413 123 115 138 143 55 63 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
42 
disease_progression 
H-positive risk:  854 820 114 967 411 123 925 388 141 61 142 54 
H-negative risk:  820 854 925 967 388 411 123 114 142 141 54 61 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 56 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
43 
disease_progression 
H-positive risk:  849 819 115 977 405 127 929 383 142 60 142 52 
H-negative risk:  819 849 929 977 383 405 127 115 142 142 52 60 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 56 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
44 
disease_progression 
H-positive risk:  858 817 113 978 400 128 932 376 141 61 143 53 
H-negative risk:  817 858 932 978 376 400 128 113 143 141 53 61 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 57 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
45 
disease_progression 
H-positive risk:  860 816 117 978 399 129 937 369 144 57 141 53 
H-negative risk:  816 860 937 978 369 399 129 117 141 144 53 57 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 59 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
46 
disease_progression 
H-positive risk:  863 819 116 977 395 130 934 370 142 58 142 54 
H-negative risk:  819 863 934 977 370 395 130 116 142 142 54 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
47 
disease_progression 
H-positive risk:  862 820 118 970 396 133 939 367 142 58 137 58 
H-negative risk:  820 862 939 970 367 396 133 118 137 142 58 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
48 
disease_progression 
H-positive risk:  865 824 118 971 402 133 932 361 140 60 136 58 
H-negative risk:  824 865 932 971 361 402 133 118 136 140 58 60 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 63 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
49 
disease_progression 
H-positive risk:  814 769 111 1018 405 121 988 360 154 59 143 58 
H-negative risk:  769 814 988 1018 360 405 121 111 143 154 58 59 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 62 21 

clinical_engagement 
diagnosis 
demography 
145 new agents 
50 
disease_progression 
H-positive risk:  828 782 117 1012 392 123 954 384 149 58 141 60 
H-negative risk:  782 828 954 1012 384 392 123 117 141 149 60 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
51 
disease_progression 
H-positive risk:  819 785 121 1015 391 126 952 381 151 58 140 61 
H-negative risk:  785 819 952 1015 381 391 126 121 140 151 61 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
52 
disease_progression 
H-positive risk:  818 795 125 1015 388 127 947 376 153 58 137 61 
H-negative risk:  795 818 947 1015 376 388 127 125 137 153 61 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
53 
disease_progression 
H-positive risk:  829 806 127 1010 380 129 945 362 153 59 138 62 
H-negative risk:  806 829 945 1010 362 380 129 127 138 153 62 59 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
54 
disease_progression 
H-positive risk:  823 809 128 1002 386 129 950 362 153 60 137 61 
H-negative risk:  809 823 950 1002 362 386 129 128 137 153 61 60 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 63 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
55 
disease_progression 
H-positive risk:  831 810 129 995 381 129 950 357 157 62 137 62 
H-negative risk:  810 831 950 995 357 381 129 129 137 157 62 62 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
56 
disease_progression 
H-positive risk:  829 812 129 997 381 130 955 352 155 66 133 61 
H-negative risk:  812 829 955 997 352 381 130 129 133 155 61 66 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
57 
disease_progression 
H-positive risk:  833 813 131 997 372 131 957 355 156 64 133 58 
H-negative risk:  813 833 957 997 355 372 131 131 133 156 58 64 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
58 
disease_progression 
H-positive risk:  840 813 130 994 365 132 962 356 152 63 135 58 
H-negative risk:  813 840 962 994 356 365 132 130 135 152 58 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
59 
disease_progression 
H-positive risk:  843 809 128 991 366 134 967 357 150 62 135 58 
H-negative risk:  809 843 967 991 357 366 134 128 135 150 58 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
60 
disease_progression 
H-positive risk:  844 810 131 989 359 134 967 360 151 61 135 59 
H-negative risk:  810 844 967 989 360 359 134 131 135 151 59 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
61 
disease_progression 
H-positive risk:  790 758 122 1054 346 121 1026 361 162 62 140 58 
H-negative risk:  758 790 1026 1054 361 346 121 122 140 162 58 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
116 new agents 
62 
disease_progression 
H-positive risk:  791 766 121 1030 366 126 1003 371 160 67 138 61 
H-negative risk:  766 791 1003 1030 371 366 126 121 138 160 61 67 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
63 
disease_progression 
H-positive risk:  797 766 120 1026 366 127 1002 365 162 69 142 58 
H-negative risk:  766 797 1002 1026 365 366 127 120 142 162 58 69 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
64 
disease_progression 
H-positive risk:  795 771 121 1020 374 128 1000 361 159 69 144 58 
H-negative risk:  771 795 1000 1020 361 374 128 121 144 159 58 69 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
65 
disease_progression 
H-positive risk:  797 770 121 1022 368 128 1003 361 160 68 145 57 
H-negative risk:  770 797 1003 1022 361 368 128 121 145 160 57 68 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
66 
disease_progression 
H-positive risk:  794 766 122 1027 367 127 1008 363 158 67 144 57 
H-negative risk:  766 794 1008 1027 363 367 127 122 144 158 57 67 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
67 
disease_progression 
H-positive risk:  791 767 123 1024 371 130 1011 360 157 69 142 55 
H-negative risk:  767 791 1011 1024 360 371 130 123 142 157 55 69 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
68 
disease_progression 
H-positive risk:  799 768 126 1020 364 133 1017 358 152 67 140 56 
H-negative risk:  768 799 1017 1020 358 364 133 126 140 152 56 67 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
69 
disease_progression 
H-positive risk:  801 773 129 1015 365 135 1016 353 151 67 140 55 
H-negative risk:  773 801 1016 1015 353 365 135 129 140 151 55 67 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 65 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
70 
disease_progression 
H-positive risk:  804 772 128 1017 366 137 1020 344 150 67 141 54 
H-negative risk:  772 804 1020 1017 344 366 137 128 141 150 54 67 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
71 
disease_progression 
H-positive risk:  809 778 127 1011 370 137 1015 344 150 64 141 54 
H-negative risk:  778 809 1015 1011 344 370 137 127 141 150 54 64 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
72 
disease_progression 
H-positive risk:  812 783 126 1008 360 139 1016 345 147 69 142 53 
H-negative risk:  783 812 1016 1008 345 360 139 126 142 147 53 69 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 61 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
73 
disease_progression 
H-positive risk:  764 744 115 1051 362 131 1062 348 155 67 149 52 
H-negative risk:  744 764 1062 1051 348 362 131 115 149 155 52 67 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 60 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
74 
disease_progression 
H-positive risk:  772 754 118 1022 378 131 1031 370 155 66 148 55 
H-negative risk:  754 772 1031 1022 370 378 131 118 148 155 55 66 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 60 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
75 
disease_progression 
H-positive risk:  772 754 118 1012 377 132 1040 373 154 67 147 54 
H-negative risk:  754 772 1040 1012 373 377 132 118 147 154 54 67 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 58 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
76 
disease_progression 
H-positive risk:  775 753 117 1007 376 130 1043 376 155 66 146 56 
H-negative risk:  753 775 1043 1007 376 376 130 117 146 155 56 66 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 57 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
77 
disease_progression 
H-positive risk:  781 754 117 1004 377 129 1040 375 157 61 147 58 
H-negative risk:  754 781 1040 1004 375 377 129 117 147 157 58 61 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 57 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
78 
disease_progression 
H-positive risk:  788 751 118 997 376 132 1039 379 157 58 146 59 
H-negative risk:  751 788 1039 997 379 376 132 118 146 157 59 58 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 60 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
79 
disease_progression 
H-positive risk:  790 751 116 998 374 131 1035 377 156 59 150 63 
H-negative risk:  751 790 1035 998 377 374 131 116 150 156 63 59 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 60 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
80 
disease_progression 
H-positive risk:  802 749 117 989 376 131 1032 380 155 57 151 61 
H-negative risk:  749 802 1032 989 380 376 131 117 151 155 61 57 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 64 19 

clinical_engagement 
diagnosis 
demography 
53 new agents 
81 
disease_progression 
H-positive risk:  806 754 115 979 381 128 1032 378 158 57 152 60 
H-negative risk:  754 806 1032 979 378 381 128 115 152 158 60 57 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 64 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
82 
disease_progression 
H-positive risk:  804 762 118 975 374 128 1040 373 157 58 150 61 
H-negative risk:  762 804 1040 975 373 374 128 118 150 157 61 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
83 
disease_progression 
H-positive risk:  806 766 117 975 376 126 1039 373 157 55 150 60 
H-negative risk:  766 806 1039 975 373 376 126 117 150 157 60 55 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
84 
disease_progression 
H-positive risk:  801 773 116 979 376 125 1046 364 153 57 150 60 
H-negative risk:  773 801 1046 979 364 376 125 116 150 153 60 57 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
85 
disease_progression 
H-positive risk:  762 736 108 1018 366 119 1095 361 160 57 159 59 
H-negative risk:  736 762 1095 1018 361 366 119 108 159 160 59 57 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
100 new agents 
86 
disease_progression 
H-positive risk:  766 733 104 1014 378 123 1066 374 161 56 165 60 
H-negative risk:  733 766 1066 1014 374 378 123 104 165 161 60 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
87 
disease_progression 
H-positive risk:  772 737 103 1017 373 126 1059 372 160 58 164 59 
H-negative risk:  737 772 1059 1017 372 373 126 103 164 160 59 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
57 new agents 
88 
disease_progression 
H-positive risk:  761 739 101 1017 371 128 1056 382 162 57 167 59 
H-negative risk:  739 761 1056 1017 382 371 128 101 167 162 59 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
89 
disease_progression 
H-positive risk:  767 744 102 1016 360 129 1051 388 161 58 164 60 
H-negative risk:  744 767 1051 1016 388 360 129 102 164 161 60 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
90 
disease_progression 
H-positive risk:  756 754 102 1017 356 128 1058 387 161 59 162 60 
H-negative risk:  754 756 1058 1017 387 356 128 102 162 161 60 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
91 
disease_progression 
H-positive risk:  761 751 103 1010 362 129 1050 392 164 59 158 61 
H-negative risk:  751 761 1050 1010 392 362 129 103 158 164 61 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
92 
disease_progression 
H-positive risk:  755 755 105 1009 364 131 1047 395 163 59 157 60 
H-negative risk:  755 755 1047 1009 395 364 131 105 157 163 60 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
93 
disease_progression 
H-positive risk:  759 754 107 1009 361 134 1036 405 165 57 157 56 
H-negative risk:  754 759 1036 1009 405 361 134 107 157 165 56 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
94 
disease_progression 
H-positive risk:  755 759 107 1014 357 133 1032 407 166 57 157 56 
H-negative risk:  759 755 1032 1014 407 357 133 107 157 166 56 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
95 
disease_progression 
H-positive risk:  749 769 106 1016 356 133 1028 403 170 57 157 56 
H-negative risk:  769 749 1028 1016 403 356 133 106 157 170 56 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
96 
disease_progression 
H-positive risk:  752 772 107 1016 359 130 1022 405 170 58 153 56 
H-negative risk:  772 752 1022 1016 405 359 130 107 153 170 56 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
97 
disease_progression 
H-positive risk:  711 722 104 1068 356 124 1063 405 178 57 156 56 
H-negative risk:  722 711 1063 1068 405 356 124 104 156 178 56 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
120 new agents 
98 
disease_progression 
H-positive risk:  705 729 108 1071 366 125 1051 407 174 54 151 59 
H-negative risk:  729 705 1051 1071 407 366 125 108 151 174 59 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
99 
disease_progression 
H-positive risk:  712 736 106 1067 358 124 1043 414 177 53 151 59 
H-negative risk:  736 712 1043 1067 414 358 124 106 151 177 59 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
100 
disease_progression 
H-positive risk:  717 736 105 1065 351 124 1050 411 178 54 153 56 
H-negative risk:  736 717 1050 1065 411 351 124 105 153 178 56 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
101 
disease_progression 
H-positive risk:  716 738 105 1064 347 122 1048 416 180 52 155 57 
H-negative risk:  738 716 1048 1064 416 347 122 105 155 180 57 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
102 
disease_progression 
H-positive risk:  711 738 107 1055 349 124 1059 414 181 50 155 57 
H-negative risk:  738 711 1059 1055 414 349 124 107 155 181 57 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
103 
disease_progression 
H-positive risk:  710 737 107 1059 351 122 1061 414 183 47 154 55 
H-negative risk:  737 710 1061 1059 414 351 122 107 154 183 55 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
104 
disease_progression 
H-positive risk:  721 736 106 1059 350 122 1053 416 182 45 156 54 
H-negative risk:  736 721 1053 1059 416 350 122 106 156 182 54 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
105 
disease_progression 
H-positive risk:  721 739 107 1057 353 121 1050 413 181 46 156 56 
H-negative risk:  739 721 1050 1057 413 353 121 107 156 181 56 46 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
106 
disease_progression 
H-positive risk:  713 743 109 1055 360 121 1047 414 180 47 157 54 
H-negative risk:  743 713 1047 1055 414 360 121 109 157 180 54 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
107 
disease_progression 
H-positive risk:  714 739 109 1062 354 121 1050 411 180 49 159 52 
H-negative risk:  739 714 1050 1062 411 354 121 109 159 180 52 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
108 
disease_progression 
H-positive risk:  711 741 108 1062 346 122 1057 411 181 50 160 51 
H-negative risk:  741 711 1057 1062 411 346 122 108 160 181 51 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
109 
disease_progression 
H-positive risk:  673 689 104 1111 344 118 1095 413 185 52 165 51 
H-negative risk:  689 673 1095 1111 413 344 118 104 165 185 51 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
94 new agents 
110 
disease_progression 
H-positive risk:  670 695 106 1097 361 118 1082 426 181 49 156 59 
H-negative risk:  695 670 1082 1097 426 361 118 106 156 181 59 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
111 
disease_progression 
H-positive risk:  662 694 108 1084 369 118 1085 433 186 47 153 61 
H-negative risk:  694 662 1085 1084 433 369 118 108 153 186 61 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
112 
disease_progression 
H-positive risk:  658 692 108 1096 368 118 1082 431 185 45 155 62 
H-negative risk:  692 658 1082 1096 431 368 118 108 155 185 62 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
113 
disease_progression 
H-positive risk:  663 693 107 1098 367 121 1082 428 182 43 153 63 
H-negative risk:  693 663 1082 1098 428 367 121 107 153 182 63 43 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
114 
disease_progression 
H-positive risk:  666 684 106 1110 365 119 1071 429 184 45 156 65 
H-negative risk:  684 666 1071 1110 429 365 119 106 156 184 65 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
115 
disease_progression 
H-positive risk:  667 683 106 1109 365 124 1074 423 179 47 158 65 
H-negative risk:  683 667 1074 1109 423 365 124 106 158 179 65 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
116 
disease_progression 
H-positive risk:  670 686 106 1114 366 122 1073 421 177 46 155 64 
H-negative risk:  686 670 1073 1114 421 366 122 106 155 177 64 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
117 
disease_progression 
H-positive risk:  679 686 107 1114 361 121 1063 423 182 44 154 66 
H-negative risk:  686 679 1063 1114 423 361 121 107 154 182 66 44 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
118 
disease_progression 
H-positive risk:  679 686 105 1126 354 121 1063 420 183 43 158 62 
H-negative risk:  686 679 1063 1126 420 354 121 105 158 183 62 43 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
119 
disease_progression 
H-positive risk:  684 687 110 1125 356 123 1055 412 181 47 160 60 
H-negative risk:  687 684 1055 1125 412 356 123 110 160 181 60 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
120 
disease_progression 
H-positive risk:  690 690 111 1118 359 124 1055 405 180 47 160 61 
H-negative risk:  690 690 1055 1118 405 359 124 111 160 180 61 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
121 
disease_progression 
H-positive risk:  644 655 107 1145 362 116 1113 400 182 49 163 64 
H-negative risk:  655 644 1113 1145 400 362 116 107 163 182 64 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
122 
disease_progression 
H-positive risk:  653 663 106 1137 360 116 1090 419 177 51 164 64 
H-negative risk:  663 653 1090 1137 419 360 116 106 164 177 64 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
123 
disease_progression 
H-positive risk:  651 662 107 1139 359 115 1086 424 175 52 165 65 
H-negative risk:  662 651 1086 1139 424 359 115 107 165 175 65 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  647 656 108 1144 367 113 1088 422 174 52 162 67 
H-negative risk:  656 647 1088 1144 422 367 113 108 162 174 67 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
125 
disease_progression 
H-positive risk:  649 666 104 1136 363 112 1093 414 180 50 168 65 
H-negative risk:  666 649 1093 1136 414 363 112 104 168 180 65 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
126 
disease_progression 
H-positive risk:  656 673 106 1137 360 111 1089 407 177 49 170 65 
H-negative risk:  673 656 1089 1137 407 360 111 106 170 177 65 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
127 
disease_progression 
H-positive risk:  656 669 107 1143 362 110 1090 402 176 48 173 64 
H-negative risk:  669 656 1090 1143 402 362 110 107 173 176 64 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
128 
disease_progression 
H-positive risk:  657 668 105 1145 360 110 1093 403 179 49 170 61 
H-negative risk:  668 657 1093 1145 403 360 110 105 170 179 61 49 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
129 
disease_progression 
H-positive risk:  657 666 103 1138 363 110 1103 404 179 46 171 60 
H-negative risk:  666 657 1103 1138 404 363 110 103 171 179 60 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
130 
disease_progression 
H-positive risk:  650 674 101 1147 365 110 1105 401 174 45 169 59 
H-negative risk:  674 650 1105 1147 401 365 110 101 169 174 59 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
131 
disease_progression 
H-positive risk:  660 672 100 1154 354 109 1102 401 175 45 167 61 
H-negative risk:  672 660 1102 1154 401 354 109 100 167 175 61 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
132 
disease_progression 
H-positive risk:  664 667 102 1151 355 110 1108 399 173 43 168 60 
H-negative risk:  667 664 1108 1151 399 355 110 102 168 173 60 43 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
92 new agents 
133 
disease_progression 
H-positive risk:  665 675 102 1153 355 110 1107 397 172 42 168 54 
H-negative risk:  675 665 1107 1153 397 355 110 102 168 172 54 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
101 new agents 
134 
disease_progression 
H-positive risk:  668 667 101 1154 362 110 1105 396 173 40 167 57 
H-negative risk:  667 668 1105 1154 396 362 110 101 167 173 57 40 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
57 new agents 
135 
disease_progression 
H-positive risk:  663 666 99 1156 368 109 1105 393 172 43 168 58 
H-negative risk:  666 663 1105 1156 393 368 109 99 168 172 58 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
136 
disease_progression 
H-positive risk:  662 660 100 1166 374 110 1096 394 172 42 167 57 
H-negative risk:  660 662 1096 1166 394 374 110 100 167 172 57 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
137 
disease_progression 
H-positive risk:  664 652 101 1170 374 111 1095 388 172 46 169 58 
H-negative risk:  652 664 1095 1170 388 374 111 101 169 172 58 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
138 
disease_progression 
H-positive risk:  667 655 103 1160 384 113 1094 381 167 49 169 58 
H-negative risk:  655 667 1094 1160 381 384 113 103 169 167 58 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
46 new agents 
139 
disease_progression 
H-positive risk:  666 653 100 1173 383 111 1091 378 164 50 173 58 
H-negative risk:  653 666 1091 1173 378 383 111 100 173 164 58 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
140 
disease_progression 
H-positive risk:  666 650 96 1178 380 108 1092 378 170 49 172 61 
H-negative risk:  650 666 1092 1178 378 380 108 96 172 170 61 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
55 new agents 
141 
disease_progression 
H-positive risk:  669 653 97 1180 380 109 1092 368 171 48 175 58 
H-negative risk:  653 669 1092 1180 368 380 109 97 175 171 58 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
142 
disease_progression 
H-positive risk:  664 654 98 1180 380 108 1095 372 172 45 173 59 
H-negative risk:  654 664 1095 1180 372 380 108 98 173 172 59 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
143 
disease_progression 
H-positive risk:  666 644 99 1181 381 107 1096 378 172 45 173 58 
H-negative risk:  644 666 1096 1181 378 381 107 99 173 172 58 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
144 
disease_progression 
H-positive risk:  667 651 95 1172 382 104 1101 382 172 43 172 59 
H-negative risk:  651 667 1101 1172 382 382 104 95 172 172 59 43 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
145 
disease_progression 
H-positive risk:  664 652 95 1165 387 102 1105 381 174 44 171 60 
H-negative risk:  652 664 1105 1165 381 387 102 95 171 174 60 44 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
146 
disease_progression 
H-positive risk:  671 653 90 1151 402 100 1098 382 171 50 169 63 
H-negative risk:  653 671 1098 1151 382 402 100 90 169 171 63 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
147 
disease_progression 
H-positive risk:  671 663 93 1145 397 98 1105 370 178 47 169 64 
H-negative risk:  663 671 1105 1145 370 397 98 93 169 178 64 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
148 
disease_progression 
H-positive risk:  666 661 95 1148 399 95 1110 371 175 47 168 65 
H-negative risk:  661 666 1110 1148 371 399 95 95 168 175 65 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
149 
disease_progression 
H-positive risk:  667 672 96 1146 395 94 1109 371 170 49 166 65 
H-negative risk:  672 667 1109 1146 371 395 94 96 166 170 65 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
150 
disease_progression 
H-positive risk:  665 680 95 1149 391 95 1108 369 168 49 167 64 
H-negative risk:  680 665 1108 1149 369 391 95 95 167 168 64 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
58 new agents 
151 
disease_progression 
H-positive risk:  661 681 95 1145 397 96 1109 371 169 48 163 65 
H-negative risk:  681 661 1109 1145 371 397 96 95 163 169 65 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
152 
disease_progression 
H-positive risk:  655 681 93 1144 401 94 1108 374 173 47 164 66 
H-negative risk:  681 655 1108 1144 374 401 94 93 164 173 66 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
153 
disease_progression 
H-positive risk:  658 673 93 1142 411 93 1110 367 174 47 166 66 
H-negative risk:  673 658 1110 1142 367 411 93 93 166 174 66 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
154 
disease_progression 
H-positive risk:  662 677 96 1148 407 93 1102 367 173 48 162 65 
H-negative risk:  677 662 1102 1148 367 407 93 96 162 173 65 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
155 
disease_progression 
H-positive risk:  667 683 97 1152 405 90 1098 365 174 45 160 64 
H-negative risk:  683 667 1098 1152 365 405 90 97 160 174 64 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
156 
disease_progression 
H-positive risk:  677 685 98 1150 399 89 1099 362 171 46 161 63 
H-negative risk:  685 677 1099 1150 362 399 89 98 161 171 63 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
157 
disease_progression 
H-positive risk:  677 684 98 1161 392 91 1100 360 166 46 165 60 
H-negative risk:  684 677 1100 1161 360 392 91 98 165 166 60 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
158 
disease_progression 
H-positive risk:  678 669 98 1152 407 90 1089 373 168 49 167 60 
H-negative risk:  669 678 1089 1152 373 407 90 98 167 168 60 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
159 
disease_progression 
H-positive risk:  679 669 98 1148 407 89 1086 376 171 52 167 58 
H-negative risk:  669 679 1086 1148 376 407 89 98 167 171 58 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
160 
disease_progression 
H-positive risk:  679 671 102 1144 419 89 1073 378 170 53 167 55 
H-negative risk:  671 679 1073 1144 378 419 89 102 167 170 55 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
161 
disease_progression 
H-positive risk:  675 669 104 1136 417 87 1089 378 173 54 164 54 
H-negative risk:  669 675 1089 1136 378 417 87 104 164 173 54 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
162 
disease_progression 
H-positive risk:  673 666 104 1139 418 90 1089 378 174 53 162 54 
H-negative risk:  666 673 1089 1139 378 418 90 104 162 174 54 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
163 
disease_progression 
H-positive risk:  670 665 101 1144 421 90 1096 375 173 53 159 53 
H-negative risk:  665 670 1096 1144 375 421 90 101 159 173 53 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
164 
disease_progression 
H-positive risk:  668 668 101 1135 425 89 1099 375 176 54 156 54 
H-negative risk:  668 668 1099 1135 375 425 89 101 156 176 54 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
165 
disease_progression 
H-positive risk:  658 673 101 1126 429 90 1118 368 176 54 157 50 
H-negative risk:  673 658 1118 1126 368 429 90 101 157 176 50 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
166 
disease_progression 
H-positive risk:  658 681 100 1122 430 91 1111 368 177 53 157 52 
H-negative risk:  681 658 1111 1122 368 430 91 100 157 177 52 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
167 
disease_progression 
H-positive risk:  659 679 97 1124 422 90 1113 371 180 53 158 54 
H-negative risk:  679 659 1113 1124 371 422 90 97 158 180 54 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
168 
disease_progression 
H-positive risk:  660 671 101 1124 425 89 1120 365 180 55 157 53 
H-negative risk:  671 660 1120 1124 365 425 89 101 157 180 53 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
169 
disease_progression 
H-positive risk:  659 672 103 1121 427 88 1123 363 178 56 154 56 
H-negative risk:  672 659 1123 1121 363 427 88 103 154 178 56 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
170 
disease_progression 
H-positive risk:  659 661 103 1114 435 87 1126 371 179 57 153 55 
H-negative risk:  661 659 1126 1114 371 435 87 103 153 179 55 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
171 
disease_progression 
H-positive risk:  659 663 98 1118 427 87 1125 372 178 62 159 52 
H-negative risk:  663 659 1125 1118 372 427 87 98 159 178 52 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
172 
disease_progression 
H-positive risk:  656 666 99 1111 426 90 1127 374 177 62 160 52 
H-negative risk:  666 656 1127 1111 374 426 90 99 160 177 52 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
173 
disease_progression 
H-positive risk:  657 667 98 1104 430 89 1116 385 180 63 161 50 
H-negative risk:  667 657 1116 1104 385 430 89 98 161 180 50 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
174 
disease_progression 
H-positive risk:  661 656 97 1115 429 89 1111 390 178 61 162 51 
H-negative risk:  656 661 1111 1115 390 429 89 97 162 178 51 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
175 
disease_progression 
H-positive risk:  666 658 98 1107 430 89 1104 393 180 64 162 49 
H-negative risk:  658 666 1104 1107 393 430 89 98 162 180 49 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
176 
disease_progression 
H-positive risk:  663 647 96 1109 438 91 1092 403 180 65 164 52 
H-negative risk:  647 663 1092 1109 403 438 91 96 164 180 52 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
177 
disease_progression 
H-positive risk:  661 652 95 1118 433 91 1092 394 182 65 165 52 
H-negative risk:  652 661 1092 1118 394 433 91 95 165 182 52 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
178 
disease_progression 
H-positive risk:  659 655 89 1128 432 89 1092 390 184 64 167 51 
H-negative risk:  655 659 1092 1128 390 432 89 89 167 184 51 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
179 
disease_progression 
H-positive risk:  659 652 91 1131 429 87 1094 391 186 63 167 50 
H-negative risk:  652 659 1094 1131 391 429 87 91 167 186 50 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
180 
disease_progression 
H-positive risk:  647 647 91 1145 419 85 1097 400 188 63 166 52 
H-negative risk:  647 647 1097 1145 400 419 85 91 166 188 52 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
181 
disease_progression 
H-positive risk:  645 654 90 1145 420 85 1094 402 185 64 165 51 
H-negative risk:  654 645 1094 1145 402 420 85 90 165 185 51 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
182 
disease_progression 
H-positive risk:  646 650 91 1150 425 82 1085 403 183 67 162 56 
H-negative risk:  650 646 1085 1150 403 425 82 91 162 183 56 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
183 
disease_progression 
H-positive risk:  651 652 91 1159 421 81 1076 400 183 68 163 55 
H-negative risk:  652 651 1076 1159 400 421 81 91 163 183 55 68 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
184 
disease_progression 
H-positive risk:  653 651 89 1169 422 78 1077 393 179 70 165 54 
H-negative risk:  651 653 1077 1169 393 422 78 89 165 179 54 70 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
185 
disease_progression 
H-positive risk:  651 649 88 1173 424 79 1082 384 183 70 164 53 
H-negative risk:  649 651 1082 1173 384 424 79 88 164 183 53 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
186 
disease_progression 
H-positive risk:  646 661 85 1169 429 79 1088 374 183 69 166 51 
H-negative risk:  661 646 1088 1169 374 429 79 85 166 183 51 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
187 
disease_progression 
H-positive risk:  641 665 84 1163 428 80 1096 373 185 67 167 51 
H-negative risk:  665 641 1096 1163 373 428 80 84 167 185 51 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
188 
disease_progression 
H-positive risk:  643 668 85 1162 427 79 1098 367 186 67 166 52 
H-negative risk:  668 643 1098 1162 367 427 79 85 166 186 52 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
56 new agents 
189 
disease_progression 
H-positive risk:  643 656 85 1170 422 78 1103 374 186 64 166 53 
H-negative risk:  656 643 1103 1170 374 422 78 85 166 186 53 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
190 
disease_progression 
H-positive risk:  651 653 87 1169 413 78 1109 373 183 69 163 52 
H-negative risk:  653 651 1109 1169 373 413 78 87 163 183 52 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
191 
disease_progression 
H-positive risk:  652 661 89 1168 412 78 1104 370 179 68 166 53 
H-negative risk:  661 652 1104 1168 370 412 78 89 166 179 53 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
192 
disease_progression 
H-positive risk:  655 653 87 1171 416 81 1104 370 177 67 167 52 
H-negative risk:  653 655 1104 1171 370 416 81 87 167 177 52 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
193 
disease_progression 
H-positive risk:  660 659 89 1172 408 82 1096 373 177 68 162 54 
H-negative risk:  659 660 1096 1172 373 408 82 89 162 177 54 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
194 
disease_progression 
H-positive risk:  645 657 88 1174 418 83 1093 388 175 66 161 52 
H-negative risk:  657 645 1093 1174 388 418 83 88 161 175 52 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
195 
disease_progression 
H-positive risk:  648 654 89 1179 418 81 1087 393 171 69 158 53 
H-negative risk:  654 648 1087 1179 393 418 81 89 158 171 53 69 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
88 new agents 
196 
disease_progression 
H-positive risk:  655 661 88 1182 413 79 1081 396 170 65 157 53 
H-negative risk:  661 655 1081 1182 396 413 79 88 157 170 53 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
197 
disease_progression 
H-positive risk:  655 660 89 1180 417 80 1080 393 172 65 156 53 
H-negative risk:  660 655 1080 1180 393 417 80 89 156 172 53 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
198 
disease_progression 
H-positive risk:  655 651 85 1184 414 82 1085 394 170 63 160 57 
H-negative risk:  651 655 1085 1184 394 414 82 85 160 170 57 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
199 
disease_progression 
H-positive risk:  654 657 86 1173 416 84 1084 395 170 63 161 57 
H-negative risk:  657 654 1084 1173 395 416 84 86 161 170 57 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
200 
disease_progression 
H-positive risk:  665 657 82 1165 412 87 1079 406 167 61 160 59 
H-negative risk:  657 665 1079 1165 406 412 87 82 160 167 59 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
201 
disease_progression 
H-positive risk:  667 663 77 1160 410 85 1083 414 167 60 158 56 
H-negative risk:  663 667 1083 1160 414 410 85 77 158 167 56 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
202 
disease_progression 
H-positive risk:  659 663 79 1163 406 85 1088 418 168 57 157 57 
H-negative risk:  663 659 1088 1163 418 406 85 79 157 168 57 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
203 
disease_progression 
H-positive risk:  656 668 82 1162 403 84 1088 416 169 58 156 58 
H-negative risk:  668 656 1088 1162 416 403 84 82 156 169 58 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
204 
disease_progression 
H-positive risk:  653 666 84 1164 401 81 1093 415 166 64 155 58 
H-negative risk:  666 653 1093 1164 415 401 81 84 155 166 58 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
205 
disease_progression 
H-positive risk:  652 665 86 1155 403 81 1097 422 165 63 156 55 
H-negative risk:  665 652 1097 1155 422 403 81 86 156 165 55 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
206 
disease_progression 
H-positive risk:  645 660 84 1148 411 88 1090 438 161 63 154 58 
H-negative risk:  660 645 1090 1148 438 411 88 84 154 161 58 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
207 
disease_progression 
H-positive risk:  638 656 83 1138 417 90 1093 450 159 61 152 63 
H-negative risk:  656 638 1093 1138 450 417 90 83 152 159 63 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
208 
disease_progression 
H-positive risk:  645 648 82 1133 417 93 1100 451 156 61 155 59 
H-negative risk:  648 645 1100 1133 451 417 93 82 155 156 59 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
209 
disease_progression 
H-positive risk:  645 646 81 1134 422 93 1105 448 157 56 156 57 
H-negative risk:  646 645 1105 1134 448 422 93 81 156 157 57 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
210 
disease_progression 
H-positive risk:  645 651 79 1130 420 91 1110 441 158 59 157 59 
H-negative risk:  651 645 1110 1130 441 420 91 79 157 158 59 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
211 
disease_progression 
H-positive risk:  654 644 77 1133 418 89 1107 439 162 59 157 61 
H-negative risk:  644 654 1107 1133 439 418 89 77 157 162 61 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
212 
disease_progression 
H-positive risk:  655 636 77 1132 429 87 1110 436 161 58 159 60 
H-negative risk:  636 655 1110 1132 436 429 87 77 159 161 60 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
213 
disease_progression 
H-positive risk:  657 637 78 1130 433 88 1108 434 164 57 156 58 
H-negative risk:  637 657 1108 1130 434 433 88 78 156 164 58 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
214 
disease_progression 
H-positive risk:  660 638 79 1134 433 88 1104 432 163 58 152 59 
H-negative risk:  638 660 1104 1134 432 433 88 79 152 163 59 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
215 
disease_progression 
H-positive risk:  660 643 74 1134 430 88 1103 435 160 59 156 58 
H-negative risk:  643 660 1103 1134 435 430 88 74 156 160 58 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
216 
disease_progression 
H-positive risk:  650 644 74 1126 435 89 1119 430 160 59 156 58 
H-negative risk:  644 650 1119 1126 430 435 89 74 156 160 58 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
217 
disease_progression 
H-positive risk:  652 649 77 1102 456 90 1103 439 158 61 154 59 
H-negative risk:  649 652 1103 1102 439 456 90 77 154 158 59 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
218 
disease_progression 
H-positive risk:  656 647 78 1100 446 87 1107 441 159 63 157 59 
H-negative risk:  647 656 1107 1100 441 446 87 78 157 159 59 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
219 
disease_progression 
H-positive risk:  648 648 79 1088 456 90 1106 445 163 60 157 60 
H-negative risk:  648 648 1106 1088 445 456 90 79 157 163 60 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
220 
disease_progression 
H-positive risk:  651 653 76 1090 456 87 1108 441 159 63 157 59 
H-negative risk:  653 651 1108 1090 441 456 87 76 157 159 59 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
221 
disease_progression 
H-positive risk:  648 654 75 1090 456 90 1117 435 156 65 154 60 
H-negative risk:  654 648 1117 1090 435 456 90 75 154 156 60 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
222 
disease_progression 
H-positive risk:  653 650 74 1093 457 90 1115 436 155 64 155 58 
H-negative risk:  650 653 1115 1093 436 457 90 74 155 155 58 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
93 new agents 
223 
disease_progression 
H-positive risk:  651 650 75 1099 455 90 1118 433 153 61 154 61 
H-negative risk:  650 651 1118 1099 433 455 90 75 154 153 61 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
224 
disease_progression 
H-positive risk:  653 648 72 1100 454 93 1120 432 150 60 158 60 
H-negative risk:  648 653 1120 1100 432 454 93 72 158 150 60 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
225 
disease_progression 
H-positive risk:  654 646 72 1109 452 92 1114 432 149 61 160 59 
H-negative risk:  646 654 1114 1109 432 452 92 72 160 149 59 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
226 
disease_progression 
H-positive risk:  655 648 69 1104 455 90 1112 433 152 61 162 59 
H-negative risk:  648 655 1112 1104 433 455 90 69 162 152 59 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
227 
disease_progression 
H-positive risk:  648 648 67 1106 449 92 1120 429 154 61 164 62 
H-negative risk:  648 648 1120 1106 429 449 92 67 164 154 62 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
228 
disease_progression 
H-positive risk:  648 651 67 1107 447 93 1126 421 152 63 163 62 
H-negative risk:  651 648 1126 1107 421 447 93 67 163 152 62 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
229 
disease_progression 
H-positive risk:  649 653 65 1091 467 94 1118 429 149 64 161 60 
H-negative risk:  653 649 1118 1091 429 467 94 65 161 149 60 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
230 
disease_progression 
H-positive risk:  644 660 64 1095 473 91 1115 424 149 65 160 60 
H-negative risk:  660 644 1115 1095 424 473 91 64 160 149 60 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
231 
disease_progression 
H-positive risk:  649 672 65 1076 481 90 1111 426 146 66 160 58 
H-negative risk:  672 649 1111 1076 426 481 90 65 160 146 58 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  652 669 65 1081 478 89 1099 437 148 62 160 60 
H-negative risk:  669 652 1099 1081 437 478 89 65 160 148 60 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
233 
disease_progression 
H-positive risk:  642 670 68 1085 471 86 1104 445 148 61 159 61 
H-negative risk:  670 642 1104 1085 445 471 86 68 159 148 61 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
234 
disease_progression 
H-positive risk:  643 671 71 1090 463 87 1107 438 151 59 160 60 
H-negative risk:  671 643 1107 1090 438 463 87 71 160 151 60 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
235 
disease_progression 
H-positive risk:  640 678 68 1088 459 86 1109 437 153 59 163 60 
H-negative risk:  678 640 1109 1088 437 459 86 68 163 153 60 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
236 
disease_progression 
H-positive risk:  639 680 69 1086 457 85 1113 433 155 60 164 59 
H-negative risk:  680 639 1113 1086 433 457 85 69 164 155 59 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
237 
disease_progression 
H-positive risk:  638 676 71 1088 459 88 1110 435 154 62 162 57 
H-negative risk:  676 638 1110 1088 435 459 88 71 162 154 57 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
238 
disease_progression 
H-positive risk:  641 674 73 1075 466 89 1109 438 150 63 162 60 
H-negative risk:  674 641 1109 1075 438 466 89 73 162 150 60 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
239 
disease_progression 
H-positive risk:  643 674 72 1071 472 89 1103 438 151 65 162 60 
H-negative risk:  674 643 1103 1071 438 472 89 72 162 151 60 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
240 
disease_progression 
H-positive risk:  641 675 73 1073 475 88 1096 438 151 65 162 63 
H-negative risk:  675 641 1096 1073 438 475 88 73 162 151 63 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
241 
disease_progression 
H-positive risk:  642 672 74 1086 473 88 1074 449 147 69 161 65 
H-negative risk:  672 642 1074 1086 449 473 88 74 161 147 65 69 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
242 
disease_progression 
H-positive risk:  644 668 72 1092 474 88 1078 449 144 67 162 62 
H-negative risk:  668 644 1078 1092 449 474 88 72 162 144 62 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
243 
disease_progression 
H-positive risk:  645 675 76 1089 475 89 1084 439 144 67 158 59 
H-negative risk:  675 645 1084 1089 439 475 89 76 158 144 59 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
244 
disease_progression 
H-positive risk:  644 670 74 1084 476 90 1100 437 142 68 157 58 
H-negative risk:  670 644 1100 1084 437 476 90 74 157 142 58 68 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
245 
disease_progression 
H-positive risk:  639 672 73 1084 475 89 1103 434 145 69 156 61 
H-negative risk:  672 639 1103 1084 434 475 89 73 156 145 61 69 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
246 
disease_progression 
H-positive risk:  641 675 75 1075 478 89 1111 427 141 73 155 60 
H-negative risk:  675 641 1111 1075 427 478 89 75 155 141 60 73 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
247 
disease_progression 
H-positive risk:  643 677 76 1074 475 91 1116 429 139 73 150 57 
H-negative risk:  677 643 1116 1074 429 475 91 76 150 139 57 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
248 
disease_progression 
H-positive risk:  650 680 78 1064 471 93 1123 421 138 75 150 57 
H-negative risk:  680 650 1123 1064 421 471 93 78 150 138 57 75 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
249 
disease_progression 
H-positive risk:  651 680 80 1061 471 94 1122 420 137 78 148 58 
H-negative risk:  680 651 1122 1061 420 471 94 80 148 137 58 78 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
250 
disease_progression 
H-positive risk:  654 679 80 1060 461 93 1115 434 137 79 148 60 
H-negative risk:  679 654 1115 1060 434 461 93 80 148 137 60 79 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
251 
disease_progression 
H-positive risk:  649 673 81 1070 463 94 1115 432 136 79 145 63 
H-negative risk:  673 649 1115 1070 432 463 94 81 145 136 63 79 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
252 
disease_progression 
H-positive risk:  653 668 80 1062 466 93 1119 439 133 79 145 63 
H-negative risk:  668 653 1119 1062 439 466 93 80 145 133 63 79 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
253 
disease_progression 
H-positive risk:  648 660 81 1057 473 95 1128 440 136 78 144 60 
H-negative risk:  660 648 1128 1057 440 473 95 81 144 136 60 78 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
254 
disease_progression 
H-positive risk:  648 659 86 1057 468 95 1139 434 134 77 142 61 
H-negative risk:  659 648 1139 1057 434 468 95 86 142 134 61 77 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
255 
disease_progression 
H-positive risk:  658 663 85 1059 466 93 1127 439 134 76 141 59 
H-negative risk:  663 658 1127 1059 439 466 93 85 141 134 59 76 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
93 new agents 
256 
disease_progression 
H-positive risk:  657 671 83 1060 465 92 1129 436 134 76 140 57 
H-negative risk:  671 657 1129 1060 436 465 92 83 140 134 57 76 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
257 
disease_progression 
H-positive risk:  656 670 82 1061 460 93 1131 440 132 76 142 57 
H-negative risk:  670 656 1131 1061 440 460 93 82 142 132 57 76 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
89 new agents 
258 
disease_progression 
H-positive risk:  651 670 87 1062 462 98 1133 435 130 74 141 57 
H-negative risk:  670 651 1133 1062 435 462 98 87 141 130 57 74 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
259 
disease_progression 
H-positive risk:  657 673 86 1061 467 98 1119 437 130 71 144 57 
H-negative risk:  673 657 1119 1061 437 467 98 86 144 130 57 71 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
260 
disease_progression 
H-positive risk:  656 671 87 1063 470 97 1110 436 135 70 147 58 
H-negative risk:  671 656 1110 1063 436 470 97 87 147 135 58 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
261 
disease_progression 
H-positive risk:  647 673 85 1056 473 98 1119 441 135 67 147 59 
H-negative risk:  673 647 1119 1056 441 473 98 85 147 135 59 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
262 
disease_progression 
H-positive risk:  648 668 84 1063 471 95 1118 443 135 67 152 56 
H-negative risk:  668 648 1118 1063 443 471 95 84 152 135 56 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
263 
disease_progression 
H-positive risk:  648 663 83 1071 463 98 1115 450 132 68 152 57 
H-negative risk:  663 648 1115 1071 450 463 98 83 152 132 57 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
60 new agents 
264 
disease_progression 
H-positive risk:  646 669 83 1064 470 100 1116 446 133 63 152 58 
H-negative risk:  669 646 1116 1064 446 470 100 83 152 133 58 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
63 new agents 
265 
disease_progression 
H-positive risk:  652 671 83 1061 474 101 1112 441 132 62 153 58 
H-negative risk:  671 652 1112 1061 441 474 101 83 153 132 58 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
90 new agents 
266 
disease_progression 
H-positive risk:  656 678 84 1053 465 105 1113 442 132 65 155 52 
H-negative risk:  678 656 1113 1053 442 465 105 84 155 132 52 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
87 new agents 
267 
disease_progression 
H-positive risk:  652 674 85 1060 463 104 1121 439 133 63 155 51 
H-negative risk:  674 652 1121 1060 439 463 104 85 155 133 51 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 69 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
268 
disease_progression 
H-positive risk:  648 679 84 1071 451 101 1126 438 134 61 156 51 
H-negative risk:  679 648 1126 1071 438 451 101 84 156 134 51 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 68 34 

clinical_engagement 
diagnosis 
demography 
85 new agents 
269 
disease_progression 
H-positive risk:  635 681 86 1079 444 101 1132 437 136 62 151 56 
H-negative risk:  681 635 1132 1079 437 444 101 86 151 136 56 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 68 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
270 
disease_progression 
H-positive risk:  636 679 85 1085 437 98 1137 436 139 60 151 57 
H-negative risk:  679 636 1137 1085 436 437 98 85 151 139 57 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 67 32 

clinical_engagement 
diagnosis 
demography 
90 new agents 
271 
disease_progression 
H-positive risk:  651 670 87 1088 430 99 1136 431 139 62 146 61 
H-negative risk:  670 651 1136 1088 431 430 99 87 146 139 61 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
272 
disease_progression 
H-positive risk:  651 674 84 1094 431 96 1142 418 142 61 143 64 
H-negative risk:  674 651 1142 1094 418 431 96 84 143 142 64 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
273 
disease_progression 
H-positive risk:  651 674 84 1083 433 96 1142 425 142 64 141 65 
H-negative risk:  674 651 1142 1083 425 433 96 84 141 142 65 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
274 
disease_progression 
H-positive risk:  654 672 86 1078 433 97 1132 431 146 64 144 63 
H-negative risk:  672 654 1132 1078 431 433 97 86 144 146 63 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
92 new agents 
275 
disease_progression 
H-positive risk:  658 672 90 1074 429 99 1128 430 147 62 146 65 
H-negative risk:  672 658 1128 1074 430 429 99 90 146 147 65 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
276 
disease_progression 
H-positive risk:  653 673 91 1073 420 100 1138 429 146 65 141 71 
H-negative risk:  673 653 1138 1073 429 420 100 91 141 146 71 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
277 
disease_progression 
H-positive risk:  652 677 90 1075 424 101 1137 422 147 67 143 65 
H-negative risk:  677 652 1137 1075 422 424 101 90 143 147 65 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
278 
disease_progression 
H-positive risk:  647 685 90 1071 425 99 1144 417 144 68 145 65 
H-negative risk:  685 647 1144 1071 417 425 99 90 145 144 65 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
279 
disease_progression 
H-positive risk:  648 686 91 1068 429 99 1150 412 140 67 144 66 
H-negative risk:  686 648 1150 1068 412 429 99 91 144 140 66 67 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
280 
disease_progression 
H-positive risk:  651 688 90 1064 426 103 1143 421 143 63 144 64 
H-negative risk:  688 651 1143 1064 421 426 103 90 144 143 64 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
281 
disease_progression 
H-positive risk:  654 692 88 1059 432 100 1145 414 143 63 146 64 
H-negative risk:  692 654 1145 1059 414 432 100 88 146 143 64 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
282 
disease_progression 
H-positive risk:  649 695 88 1059 438 98 1140 410 143 68 150 62 
H-negative risk:  695 649 1140 1059 410 438 98 88 150 143 62 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
283 
disease_progression 
H-positive risk:  652 702 87 1058 443 98 1141 397 143 69 148 62 
H-negative risk:  702 652 1141 1058 397 443 98 87 148 143 62 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
284 
disease_progression 
H-positive risk:  644 703 86 1064 437 99 1148 398 144 67 150 60 
H-negative risk:  703 644 1148 1064 398 437 99 86 150 144 60 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
285 
disease_progression 
H-positive risk:  647 705 86 1075 429 99 1145 392 143 67 150 62 
H-negative risk:  705 647 1145 1075 392 429 99 86 150 143 62 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
286 
disease_progression 
H-positive risk:  634 704 87 1076 426 102 1152 397 141 66 150 65 
H-negative risk:  704 634 1152 1076 397 426 102 87 150 141 65 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
287 
disease_progression 
H-positive risk:  640 712 84 1078 426 100 1150 393 143 63 151 60 
H-negative risk:  712 640 1150 1078 393 426 100 84 151 143 60 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
288 
disease_progression 
H-positive risk:  644 709 87 1073 423 101 1143 400 146 65 150 59 
H-negative risk:  709 644 1143 1073 400 423 101 87 150 146 59 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
289 
disease_progression 
H-positive risk:  644 707 87 1082 422 102 1143 396 147 66 146 58 
H-negative risk:  707 644 1143 1082 396 422 102 87 146 147 58 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
93 new agents 
290 
disease_progression 
H-positive risk:  645 705 85 1095 423 100 1137 395 149 64 146 56 
H-negative risk:  705 645 1137 1095 395 423 100 85 146 149 56 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
291 
disease_progression 
H-positive risk:  646 708 86 1098 418 103 1132 399 145 64 144 57 
H-negative risk:  708 646 1132 1098 399 418 103 86 144 145 57 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
292 
disease_progression 
H-positive risk:  642 713 87 1102 412 107 1133 399 141 64 141 59 
H-negative risk:  713 642 1133 1102 399 412 107 87 141 141 59 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
293 
disease_progression 
H-positive risk:  645 709 88 1097 416 109 1131 400 142 62 141 60 
H-negative risk:  709 645 1131 1097 400 416 109 88 141 142 60 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
68 new agents 
294 
disease_progression 
H-positive risk:  645 705 88 1100 421 110 1129 398 141 63 138 62 
H-negative risk:  705 645 1129 1100 398 421 110 88 138 141 62 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
295 
disease_progression 
H-positive risk:  645 702 87 1098 422 109 1129 399 144 62 141 62 
H-negative risk:  702 645 1129 1098 399 422 109 87 141 144 62 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
296 
disease_progression 
H-positive risk:  647 705 85 1100 423 110 1126 394 143 62 143 62 
H-negative risk:  705 647 1126 1100 394 423 110 85 143 143 62 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
297 
disease_progression 
H-positive risk:  642 698 86 1110 423 113 1120 398 143 62 144 61 
H-negative risk:  698 642 1120 1110 398 423 113 86 144 143 61 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
298 
disease_progression 
H-positive risk:  651 696 90 1100 424 112 1121 396 146 60 146 58 
H-negative risk:  696 651 1121 1100 396 424 112 90 146 146 58 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
299 
disease_progression 
H-positive risk:  650 692 88 1106 415 111 1136 389 151 60 141 61 
H-negative risk:  692 650 1136 1106 389 415 111 88 141 151 61 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
300 
disease_progression 
H-positive risk:  650 695 89 1102 410 110 1141 394 147 62 141 59 
H-negative risk:  695 650 1141 1102 394 410 110 89 141 147 59 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
301 
disease_progression 
H-positive risk:  660 700 87 1094 407 107 1136 398 150 61 141 59 
H-negative risk:  700 660 1136 1094 398 407 107 87 141 150 59 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
302 
disease_progression 
H-positive risk:  659 699 86 1113 408 108 1134 387 147 61 142 56 
H-negative risk:  699 659 1134 1113 387 408 108 86 142 147 56 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
303 
disease_progression 
H-positive risk:  658 694 84 1123 400 107 1135 396 139 63 144 57 
H-negative risk:  694 658 1135 1123 396 400 107 84 144 139 57 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 80 35 

clinical_engagement 
diagnosis 
demography 
96 new agents 
304 
disease_progression 
H-positive risk:  666 694 81 1122 394 107 1134 393 141 64 148 56 
H-negative risk:  694 666 1134 1122 393 394 107 81 148 141 56 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 81 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
305 
disease_progression 
H-positive risk:  663 684 79 1117 395 105 1140 404 140 68 149 56 
H-negative risk:  684 663 1140 1117 404 395 105 79 149 140 56 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
306 
disease_progression 
H-positive risk:  662 683 77 1122 396 107 1134 408 140 66 149 56 
H-negative risk:  683 662 1134 1122 408 396 107 77 149 140 56 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
61 new agents 
307 
disease_progression 
H-positive risk:  661 675 78 1123 398 109 1137 410 140 67 146 56 
H-negative risk:  675 661 1137 1123 410 398 109 78 146 140 56 67 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
62 new agents 
308 
disease_progression 
H-positive risk:  666 675 77 1123 394 109 1132 415 141 65 146 57 
H-negative risk:  675 666 1132 1123 415 394 109 77 146 141 57 65 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 90 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
309 
disease_progression 
H-positive risk:  670 677 77 1125 397 106 1124 418 139 64 143 60 
H-negative risk:  677 670 1124 1125 418 397 106 77 143 139 60 64 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
88 new agents 
310 
disease_progression 
H-positive risk:  675 677 76 1123 407 107 1116 416 140 61 143 59 
H-negative risk:  677 675 1116 1123 416 407 107 76 143 140 59 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 92 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
311 
disease_progression 
H-positive risk:  674 680 79 1118 406 106 1114 421 138 61 143 60 
H-negative risk:  680 674 1114 1118 421 406 106 79 143 138 60 61 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
312 
disease_progression 
H-positive risk:  680 676 78 1118 409 107 1110 421 139 60 142 60 
H-negative risk:  676 680 1110 1118 421 409 107 78 142 139 60 60 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
313 
disease_progression 
H-positive risk:  684 681 78 1114 404 108 1110 421 137 60 140 63 
H-negative risk:  681 684 1110 1114 421 404 108 78 140 137 63 60 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
314 
disease_progression 
H-positive risk:  686 670 78 1111 417 104 1104 430 138 62 140 60 
H-negative risk:  670 686 1104 1111 430 417 104 78 140 138 60 62 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
92 new agents 
315 
disease_progression 
H-positive risk:  693 672 79 1112 406 103 1097 440 140 60 138 60 
H-negative risk:  672 693 1097 1112 440 406 103 79 138 140 60 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
316 
disease_progression 
H-positive risk:  684 678 79 1116 409 103 1098 435 140 58 138 62 
H-negative risk:  678 684 1098 1116 435 409 103 79 138 140 62 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
317 
disease_progression 
H-positive risk:  685 672 77 1126 413 103 1092 437 140 57 138 60 
H-negative risk:  672 685 1092 1126 437 413 103 77 138 140 60 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
318 
disease_progression 
H-positive risk:  684 670 81 1128 410 103 1077 451 142 58 135 61 
H-negative risk:  670 684 1077 1128 451 410 103 81 135 142 61 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
319 
disease_progression 
H-positive risk:  686 666 82 1133 409 102 1083 448 139 57 135 60 
H-negative risk:  666 686 1083 1133 448 409 102 82 135 139 60 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
320 
disease_progression 
H-positive risk:  681 657 84 1138 414 101 1081 450 140 58 137 59 
H-negative risk:  657 681 1081 1138 450 414 101 84 137 140 59 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
321 
disease_progression 
H-positive risk:  680 658 85 1136 414 98 1085 450 139 59 137 59 
H-negative risk:  658 680 1085 1136 450 414 98 85 137 139 59 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
322 
disease_progression 
H-positive risk:  680 656 88 1130 421 100 1090 441 142 56 138 58 
H-negative risk:  656 680 1090 1130 441 421 100 88 138 142 58 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
323 
disease_progression 
H-positive risk:  674 662 86 1141 411 101 1093 442 140 57 136 57 
H-negative risk:  662 674 1093 1141 442 411 101 86 136 140 57 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
324 
disease_progression 
H-positive risk:  669 659 84 1140 403 103 1106 448 137 58 139 54 
H-negative risk:  659 669 1106 1140 448 403 103 84 139 137 54 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
325 
disease_progression 
H-positive risk:  662 661 86 1137 405 102 1108 449 139 57 139 55 
H-negative risk:  661 662 1108 1137 449 405 102 86 139 139 55 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
326 
disease_progression 
H-positive risk:  658 663 85 1131 397 102 1112 457 139 56 142 58 
H-negative risk:  663 658 1112 1131 457 397 102 85 142 139 58 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
327 
disease_progression 
H-positive risk:  664 658 87 1135 396 101 1111 453 138 57 142 58 
H-negative risk:  658 664 1111 1135 453 396 101 87 142 138 58 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
328 
disease_progression 
H-positive risk:  667 666 86 1138 401 102 1094 458 136 53 142 57 
H-negative risk:  666 667 1094 1138 458 401 102 86 142 136 57 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
66 new agents 
329 
disease_progression 
H-positive risk:  666 666 85 1132 409 102 1081 466 140 54 142 57 
H-negative risk:  666 666 1081 1132 466 409 102 85 142 140 57 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
82 new agents 
330 
disease_progression 
H-positive risk:  671 677 89 1129 408 104 1074 458 141 53 140 56 
H-negative risk:  677 671 1074 1129 458 408 104 89 140 141 56 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
331 
disease_progression 
H-positive risk:  679 670 90 1135 407 102 1068 458 143 53 140 55 
H-negative risk:  670 679 1068 1135 458 407 102 90 140 143 55 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
332 
disease_progression 
H-positive risk:  674 670 91 1135 408 101 1079 456 139 50 139 58 
H-negative risk:  670 674 1079 1135 456 408 101 91 139 139 58 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
333 
disease_progression 
H-positive risk:  675 678 92 1124 411 96 1080 455 139 52 138 60 
H-negative risk:  678 675 1080 1124 455 411 96 92 138 139 60 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
334 
disease_progression 
H-positive risk:  667 681 90 1132 405 96 1090 451 138 51 141 58 
H-negative risk:  681 667 1090 1132 451 405 96 90 141 138 58 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
335 
disease_progression 
H-positive risk:  674 682 90 1128 401 97 1089 446 141 51 143 58 
H-negative risk:  682 674 1089 1128 446 401 97 90 143 141 58 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
336 
disease_progression 
H-positive risk:  678 677 89 1132 398 94 1089 453 143 49 143 55 
H-negative risk:  677 678 1089 1132 453 398 94 89 143 143 55 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
337 
disease_progression 
H-positive risk:  681 678 90 1133 401 93 1091 443 145 49 144 52 
H-negative risk:  678 681 1091 1133 443 401 93 90 144 145 52 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
338 
disease_progression 
H-positive risk:  678 669 87 1140 404 95 1089 446 147 45 145 55 
H-negative risk:  669 678 1089 1140 446 404 95 87 145 147 55 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
339 
disease_progression 
H-positive risk:  680 668 86 1146 403 93 1090 444 146 44 146 54 
H-negative risk:  668 680 1090 1146 444 403 93 86 146 146 54 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
63 new agents 
340 
disease_progression 
H-positive risk:  678 671 84 1148 404 92 1089 443 148 44 148 51 
H-negative risk:  671 678 1089 1148 443 404 92 84 148 148 51 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
341 
disease_progression 
H-positive risk:  675 672 86 1139 411 92 1084 448 146 46 152 49 
H-negative risk:  672 675 1084 1139 448 411 92 86 152 146 49 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
342 
disease_progression 
H-positive risk:  675 674 84 1138 407 90 1081 450 149 47 154 51 
H-negative risk:  674 675 1081 1138 450 407 90 84 154 149 51 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
343 
disease_progression 
H-positive risk:  673 689 82 1122 405 92 1092 448 146 45 152 54 
H-negative risk:  689 673 1092 1122 448 405 92 82 152 146 54 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
344 
disease_progression 
H-positive risk:  674 692 81 1118 406 94 1093 446 144 45 153 54 
H-negative risk:  692 674 1093 1118 446 406 94 81 153 144 54 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
345 
disease_progression 
H-positive risk:  668 697 83 1119 403 96 1089 448 147 45 152 53 
H-negative risk:  697 668 1089 1119 448 403 96 83 152 147 53 45 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
346 
disease_progression 
H-positive risk:  669 691 83 1123 401 96 1097 441 145 49 151 54 
H-negative risk:  691 669 1097 1123 441 401 96 83 151 145 54 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
347 
disease_progression 
H-positive risk:  667 687 83 1127 404 98 1101 433 145 51 149 55 
H-negative risk:  687 667 1101 1127 433 404 98 83 149 145 55 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
348 
disease_progression 
H-positive risk:  669 695 86 1124 401 96 1097 428 145 51 152 56 
H-negative risk:  695 669 1097 1124 428 401 96 86 152 145 56 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
349 
disease_progression 
H-positive risk:  672 690 85 1121 398 97 1100 434 144 50 153 56 
H-negative risk:  690 672 1100 1121 434 398 97 85 153 144 56 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
350 
disease_progression 
H-positive risk:  678 689 87 1116 395 100 1102 428 147 49 152 57 
H-negative risk:  689 678 1102 1116 428 395 100 87 152 147 57 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
351 
disease_progression 
H-positive risk:  683 690 84 1119 390 101 1102 431 144 50 152 54 
H-negative risk:  690 683 1102 1119 431 390 101 84 152 144 54 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
352 
disease_progression 
H-positive risk:  677 687 87 1118 399 101 1099 435 138 53 149 57 
H-negative risk:  687 677 1099 1118 435 399 101 87 149 138 57 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
353 
disease_progression 
H-positive risk:  676 692 86 1117 398 99 1106 429 137 55 150 55 
H-negative risk:  692 676 1106 1117 429 398 99 86 150 137 55 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
354 
disease_progression 
H-positive risk:  684 687 89 1123 396 97 1099 434 137 52 148 54 
H-negative risk:  687 684 1099 1123 434 396 97 89 148 137 54 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
355 
disease_progression 
H-positive risk:  673 682 88 1118 405 97 1107 436 138 53 149 54 
H-negative risk:  682 673 1107 1118 436 405 97 88 149 138 54 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
356 
disease_progression 
H-positive risk:  673 677 88 1122 401 95 1109 441 136 55 147 56 
H-negative risk:  677 673 1109 1122 441 401 95 88 147 136 56 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
357 
disease_progression 
H-positive risk:  679 678 88 1120 412 97 1101 433 139 52 143 58 
H-negative risk:  678 679 1101 1120 433 412 97 88 143 139 58 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
358 
disease_progression 
H-positive risk:  690 674 87 1121 409 97 1096 432 139 50 146 59 
H-negative risk:  674 690 1096 1121 432 409 97 87 146 139 59 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
359 
disease_progression 
H-positive risk:  691 680 87 1114 412 101 1086 437 137 50 145 60 
H-negative risk:  680 691 1086 1114 437 412 101 87 145 137 60 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
360 
disease_progression 
H-positive risk:  693 686 89 1098 416 100 1084 439 140 49 143 63 
H-negative risk:  686 693 1084 1098 439 416 100 89 143 140 63 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
Time difference of 22.21706 mins
This is task 2
date
